Abstract
The design of amphipathic peptides resulted in a novel peptide with a selective ability to destabilize lipid bilayers of acidic liposomes. The newly synthesized peptide, termed mast 21, is a 21-residue long amino acid chain and can only act effectively on acidic liposomes lacking cholesterol. Moreover, mast 21 killed Gram-positive and Gram-negative bacteria, and it had no hemolytic activity. The antimicrobial and hemolytic activities paralleled the results of membrane destabilizing activity using liposomes. Circular dichroism and Trp-fluorescence emission spectra showed changes in the peptide conformation and circumstances around the peptide during interaction with liposomes. These changes were consistent with an increased α-helical content and a less polar environment for the tryptophan residue of the peptide. Mast 21 was observed under dark-field microscopy in real time attacking liposomes. Acidic liposomes were attacked, which resulted in peeling of the lipid bilayer with its subsequent destruction. © 2000 by Japan Society for Bioscience, Biotechnology, and Agrochemistry.
Author supplied keywords
Cite
CITATION STYLE
Machida, S., Niimi, S., Shi, X., Ando, Y., & Yu, Y. (2000). Design of a novel membrane-destabilizing peptide selectively acting on acidic liposomes. Bioscience, Biotechnology and Biochemistry, 64(5), 985–994. https://doi.org/10.1271/bbb.64.985
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.